Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones

Joanna Fedorowicz, Cristina D. Cruz, Małgorzata Morawska, Krzesimir Ciura, Shella Gilbert-Girard, Liliana Mazur, Heidi Mäkkylä, Polina Ilina, Kirsi Savijoki, Adyary Fallarero, Päivi Tammela, Jarosław Sączewski

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

Alkuperäiskielienglanti
Artikkeli115373
LehtiEuropean Journal of Medicinal Chemistry
Vuosikerta254
Sivumäärä14
ISSN0223-5234
DOI - pysyväislinkit
TilaJulkaistu - 5 kesäk. 2023
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Lisätietoja

Funding Information:
This work was supported by the Polish National Agency for Academic Exchange [grant number PPN/BEK/2019/1/00217]; the Academy of Finland (grant no. 321551), and Medical University of Gdańsk (Poland) subsidies. We thank OpenEye Scientific Software, Santa Fe, NM., for free academic licenses for the use of their software, and the DDCB core facility supported by the University of Helsinki (HiLIFE) and Biocenter Finland for access to bioactivity screening facilities.The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Joanna Fedorowicz reports financial support was provided by Polish National Agency for Academic Exchange. Paivi Tammela reports financial support was provided by Academy of Finland. Joanna Fedorowicz reports financial support was provided by Medical University of Gdansk. Jaroslaw Saczewski reports equipment, drugs, or supplies was provided by OpenEye Scientific Software. Paivi Tammela reports equipment, drugs, or supplies was provided by University of Helsinki.

Funding Information:
This work was supported by the Polish National Agency for Academic Exchange [grant number PPN/BEK/2019/1/00217 ]; the Academy of Finland (grant no. 321551 ), and Medical University of Gdańsk (Poland) subsidies . We thank OpenEye Scientific Software, Santa Fe, NM., for free academic licenses for the use of their software, and the DDCB core facility supported by the University of Helsinki (HiLIFE) and Biocenter Finland for access to bioactivity screening facilities.

Publisher Copyright:
© 2023 The Authors

Tieteenalat

  • 317 Farmasia
  • 116 Kemia

Siteeraa tätä